Michael H. Davidson
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$11K
Total bought / sold$226K / $25.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 15SEC | NAMSNewAmsterdam Pharma Co N.V. | Buy | 10,000792,923 held (+1%) | $22.65 | $226K | -4.7% |
| Mar 2SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell | 443,707174,144 held (−72%) | $33.25 | $14.8M | -35.1% |
| Feb 26SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 61,547463,020 held (−12%) | $36.13 | $2.2M | -40.3% |
| Feb 26SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 3,161459,859 held (−1%) | $36.46 | $115K | -40.8% |
| Feb 26SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 46,517471,595 held (−9%) | $35.11 | $1.6M | -38.6% |
| Feb 26SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 10,436461,159 held (−2%) | $35.96 | $375K | -40.0% |
| Feb 26SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 1,300459,859 held (−0%) | $36.68 | $48K | -41.2% |
| Feb 26SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 165,408477,783 held (−26%) | $33.63 | $5.6M | -35.8% |
| Feb 26SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 17,924174,144 held (−9%) | $34.44 | $617K | -37.4% |
| Jan 9SEC | NAMSNewAmsterdam Pharma Co N.V. | Sell Plan | 11,582378,859 held (−3%) | — | $0 | — |
- Buy
CEO Michael H. Davidson bought $226K of NAMS at $22.65 — first open-market purchase in our records.
- Sell
CEO Michael H. Davidson sold $14.8M of NAMS at $33.25 — cuts the stake by 72%.
- Sell
CEO Michael H. Davidson sold $2.2M of NAMS at $36.13 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Michael H. Davidson sold $115K of NAMS at $36.46 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Michael H. Davidson sold $1.6M of NAMS at $35.11 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Michael H. Davidson sold $375K of NAMS at $35.96 — pre-scheduled 10b5-1 plan sale.